Chile vs Suriname: Access to anti-retroviral drugs, female
Chile
63.0%
in 2024
Suriname
62.0%
in 2024
Chile rank
96th
Suriname rank
99th
Access to anti-retroviral drugs, female over time
- Chile
- Suriname
How they compare
Chile currently reports 63.0% against 62.0% in Suriname, a difference of 1.0%.
Across all 25 years both countries report, Chile has been ahead every year.
Chile ranks 96th and Suriname ranks 99th of 141 countries.
Chile has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chile | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.7% | 9.0% | 20.7% | Chile |
| 2010s | 56.4% | 43.9% | 12.5% | Chile |
| 2020s | 65.6% | 58.8% | 6.8% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Chile or Suriname?
- Chile, at 63.0% against 62.0% in Suriname as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Chile and Suriname?
- 1.0%, with Chile ahead.
- How many years of comparable data are there for Chile and Suriname?
- 25 years are reported by both, from 2000 to 2024.
- How do Chile and Suriname rank globally for access to anti-retroviral drugs, female?
- Chile ranks 96th and Suriname ranks 99th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.